Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |